Replies to post #383691 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Yes, 120 patients may have been treated. But, 1/2 of them would have been treated with placebo and the other half with Brilacidin.

Brinjal Thursday, 11/11/21 12:47:31 PM
Re: Jitz post# 383679 0 Post # of 383778

The Brilacidin arm and the placebo arm had 60 patients each. 2/3rd (40 patients) in the Brilacidin arm received a 5-day course, and 1/3rd (20 patients) a 3-day course (this was announced previously). 4 in the Brilacidin arm died, and ditto in the placebo arm. That's the reason for the conclusion that there was no change in mortality.

The way the PR is worded is a little confusing.

Message in reply to:
What you are saying makes sense for no showing any effect but doesn't line up with pr. Still struggling with:
..the trial, 120 patients were treated, with THREE-FOURTHS receiving 5(FIVE) days of study drug"

3/4 of 120 =90